• MJHLS Brand Logo

© 2021 MJH Life Sciences™ and Neurology Live. All rights reserved.

Peer Exchange

The Changing Landscape in the Treatment of Spinal Muscular Atrophy
EP. 1: An Overview of the SMA Classification Criteria
EP. 2: The Importance of Newborn Screening for SMA
Management of Progressive Multiple Sclerosis
EP. 1: Clinical Subtypes of MS
EP. 2: Diagnosing SPMS
EP. 3: Classification and Diagnosis of SPMS
EP. 4: Treating PPMS Versus SPMS
EP. 5: Siponimod for SPMS Treatment
EP. 6: MS Treatment: EXPAND Study Versus ASCEND Study
EP. 7: Progressive MS Treatment: Ocrelizumab
EP. 8: Patient Selection in MS Treatment
EP. 9: Nonactive MS: Treatment Therapies
EP. 10: Ibudilast for Progressive Treatment
Progress in the Treatment of Amyotrophic Lateral Sclerosis (ALS)
EP. 1: An Overview of Causes and Risk Factors for ALS
EP. 2: Diagnosing ALS: Signs and Symptoms
Recent Advances in the Treatment of Hereditary ATTR Amyloidosis (hATTR)
EP. 1: Overview of hATTR Amyloidosis
EP. 2: Prevalence of hATTR Amyloidosis
EP. 3: Disparities in Prevalence of hATTR Amyloidosis
EP. 4: Signs and Symptoms of hATTR Amyloidosis
EP. 5: Diagnosing hATTR Amyloidosis
EP. 6: Diabetes and hATTR Amyloidosis Neuropathy
EP. 7: Diagnostic Strategies in hATTR Amyloidosis
EP. 8: Genetic Testing in hATTR Amyloidosis
EP. 9: Tissue Biopsies in hATTR Amyloidosis
EP. 10: Identification of the Amyloid Protein 
EP. 11: Recent Advances in hATTR Amyloidosis Treatment
EP. 12: Evaluating hATTR Amyloidosis Therapy
Updates in the Management of Relapsing Multiple Sclerosis
EP. 1: 2017 Changes to the McDonald Criteria: Diagnosing Multiple Sclerosis
EP. 2: Use of MRI in Diagnosing Multiple Sclerosis
EP. 3: Misdiagnosis of Multiple Sclerosis
EP. 4: Cerebrospinal Fluid in Diagnosing Multiple Sclerosis
EP. 5: Challenges in Optimally Treating Multiple Sclerosis
EP. 6: QoL Issues in the Management of Multiple Sclerosis
EP. 7: Multiple Sclerosis Fatigue
EP. 8: TRIUMPHANT-MS Trial: Fatigue in MS
EP. 9: OPTIMUM Phase 3 Trial: Secondary End Point Effect on Fatigue
EP. 10: Strategies for Choosing Initial Therapy in MS
EP. 11: Anti-CD20 Monoclonal Antibodies for Treatment of RMS
EP. 12: Cladribine for Treatment of RMS
EP. 13: S1P Receptor Modulators for Treatment of RMS
EP. 14: Fumarates for Treatment of RMS
Advances in the Management of Acute Treatment of Migraine
EP. 1: Unmet Needs in the Management of Migraine
EP. 2: Acute Treatment of Migraine: Traditional Therapies
EP. 3: Evolution of Acute Treatment of Migraine
EP. 4: Acute Treatment of Migraine: Progress With Novel Medications
EP. 5: Use of 5-HT1F Agonists in Acute Treatment of Migraine
EP. 6: Safety of CGRP Receptor Antagonists vs 5-HT1F Agonists
EP. 7: Intranasal DHE in Acute Treatment of Migraine
EP. 8: Patient Selection of Novel Therapies for Migraine Treatment
EP. 9: Role of Neuromodulation for Acute Treatment of Migraine
EP. 10: Patient Selection for Neuromodulation Devices
EP. 11: Behavioral and Lifestyle Strategies for Migraine Management